Sanjay Singh, chief executive of Gennova Biopharmaceuticals in Pune and former head of malaria-vaccine antigen research for the US National Institutes of Health, talks of Maharashtra's research potential.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Additional information
Interview and statistics by K. S. Jayaraman
Rights and permissions
About this article
Cite this article
Jayaraman, K. Sanjay Singh. Nature 464, 944 (2010). https://doi.org/10.1038/nj7290-944b
Published:
Issue Date:
DOI: https://doi.org/10.1038/nj7290-944b